These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 26178318)
1. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre. Alzahrani N; Ung L; Valle SJ; Liauw W; Morris DL ANZ J Surg; 2017 Nov; 87(11):E167-E172. PubMed ID: 26178318 [TBL] [Abstract][Full Text] [Related]
2. Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery? Delhorme JB; Dupont-Kazma L; Addeo P; Lefebvre F; Triki E; Romain B; Meyer N; Bachellier P; Rohr S; Brigand C Int J Surg; 2016 Jan; 25():98-105. PubMed ID: 26607853 [TBL] [Abstract][Full Text] [Related]
3. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer. Lorimier G; Linot B; Paillocher N; Dupoiron D; Verrièle V; Wernert R; Hamy A; Capitain O Eur J Surg Oncol; 2017 Jan; 43(1):150-158. PubMed ID: 27839895 [TBL] [Abstract][Full Text] [Related]
4. Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: A bi-institutional study. Flood MP; Waters PS; Kelly ME; Shields C; Conneely J; Ramsay R; Michael M; Loveday B; Warrier SK; Mulsow J; Heriot AG Surg Oncol; 2021 Jun; 37():101553. PubMed ID: 33839444 [TBL] [Abstract][Full Text] [Related]
5. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases. Ito K; Takemura N; Inagaki F; Mihara F; Kurokawa T; Gohda Y; Kiyomatsu T; Yano H; Kokudo N World J Surg Oncol; 2019 Jun; 17(1):99. PubMed ID: 31196097 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer. Jeon Y; Park EJ; Lim JH; Baik SH World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188 [TBL] [Abstract][Full Text] [Related]
7. Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience. Navez J; Remue C; Leonard D; Bachmann R; Kartheuser A; Hubert C; Coubeau L; Komuta M; Van den Eynde M; Zech F; Jabbour N Ann Surg Oncol; 2016 Dec; 23(Suppl 5):666-673. PubMed ID: 27646023 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis. Bin Traiki TA; Fisher OM; Valle SJ; Parikh RN; Kozman MA; Glenn D; Power M; Liauw W; Alzahrani NA; Morris DL Eur J Surg Oncol; 2017 Oct; 43(10):1939-1948. PubMed ID: 28888800 [TBL] [Abstract][Full Text] [Related]
9. Influence of simultaneous liver and peritoneal resection on postoperative morbi-mortality and survival in patients with colon cancer treated with surgical cytoreduction and intraperitoneal hyperthermic chemotherapy. Morales Soriano R; Morón Canis JM; Molina Romero X; Pérez Celada J; Tejada Gavela S; Segura Sampedro JJ; Jiménez Morillas P; Díaz Jover P; García Pérez JM; Sena Ruiz F; González Argente X Cir Esp; 2017 Apr; 95(4):214-221. PubMed ID: 28400138 [TBL] [Abstract][Full Text] [Related]
10. Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence. Grange R; Rousset P; Williet N; Guesnon M; Milot L; Passot G; Phelip JM; Le Roy B; Glehen O; Kepenekian V Ann Surg Oncol; 2024 Apr; 31(4):2378-2390. PubMed ID: 38170409 [TBL] [Abstract][Full Text] [Related]
11. Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment? Pinto A; Hobeika C; Philis A; Kirzin S; Carrère N; Ghouti L Langenbecks Arch Surg; 2019 Jun; 404(4):477-488. PubMed ID: 31025165 [TBL] [Abstract][Full Text] [Related]
12. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer. Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829 [TBL] [Abstract][Full Text] [Related]
13. Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis. Flood MP; Das AA; Soucisse ML; Kong J; Ramsay RG; Michael M; Loveday BPT; Warrier SK; Heriot AG Dis Colon Rectum; 2021 Jun; 64(6):754-764. PubMed ID: 33742615 [TBL] [Abstract][Full Text] [Related]
14. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study. Mehta S; Schwarz L; Spiliotis J; Hsieh MC; Akaishi EH; Goere D; Sugarbaker PH; Baratti D; Quenet F; Bartlett DL; Villeneuve L; Kepenekian V; Eur J Surg Oncol; 2018 Nov; 44(11):1786-1792. PubMed ID: 29885982 [TBL] [Abstract][Full Text] [Related]
15. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection. Chua TC; Yan TD; Zhao J; Morris DL Eur J Surg Oncol; 2009 Dec; 35(12):1299-305. PubMed ID: 19632081 [TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study. Simkens GA; van Oudheusden TR; Braam HJ; Wiezer MJ; Nienhuijs SW; Rutten HJ; van Ramshorst B; de Hingh IH J Surg Oncol; 2016 Apr; 113(5):548-53. PubMed ID: 27110701 [TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma. Tabrizian P; Franssen B; Jibara G; Sweeney R; Sarpel U; Schwartz M; Labow D J Surg Oncol; 2014 Dec; 110(7):786-90. PubMed ID: 25091997 [TBL] [Abstract][Full Text] [Related]
18. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239 [TBL] [Abstract][Full Text] [Related]
19. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Quenet F; Goéré D; Mehta SS; Roca L; Dumont F; Hessissen M; Saint-Aubert B; Elias D Ann Surg; 2011 Aug; 254(2):294-301. PubMed ID: 21772129 [TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies. de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]